Welcome to Broadline Capital
Formed two decades ago, Broadline Capital is a global alternative investment firm focused primarily on providing capital and strategic support for category leaders and category creators that are reshaping their industry. At Broadline, we are inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their business into the next big, industry-changing company.
We seek purpose-driven companies that are positioned to create broad impact as the world continues to transition toward an economy increasingly driven by the pursuit of a Healthier, more Efficient, and more Sustainable way of life. We prefer companies that target an Addressable Market large enough to represent a promising commercial opportunity. We prefer companies whose management team has designed a clear plan aimed at creating exceptional value for all of the company's major Stakeholders – including its shareholders, contributing team members, suppliers, customers, neighbors, and society.
Broadline's principals have spent their entire careers building trust-based relationships globally. They have launched and developed successful companies, negotiated quality exits on behalf of themselves and their investors, and led some of the most creative deals in the history of their category. Our collective access to domain expertise, pragmatic operating experience, and vast network of relationships built over many years combine to help supported companies. We believe our current opportunities are among the most exciting on the planet.
New York | Miami | San Diego | Boulder | Columbus | Seoul | Shanghai | London
Broadline's proprietary investment process is designed to stretch alpha at every link of the investment value chain. We seek diversification by investing across a range of industries, geographies, transaction structures, and market capitalizations. When selecting opportunities, we take a two-pronged approach:
First, we start with a "Top-Down" view to choose thematic categories that are positioned for rapid growth, high margins, and broad impact as the world continues to transition toward an economy increasingly driven by the pursuit of a Healthier, more Efficient, and more Sustainable way of life. We selectively invest in categories where Broadline has access to relevant domain expertise and relationships.
Next, we take a "Bottom-Up" view to identify the category leaders and category creators that have a clear plan to create value and the right team in place to execute and capture the full opportunity. We prefer companies expecting a near-term liquidity event such as an IPO or M&A transaction.
We primarily focus on five thematic areas:
Sustainability and the Environment. Innovating how the world produces, stores, delivers, and utilizes Energy and monetizes Carbon Credits. Our supported companies are helping to enable the electrification of everything and the transition to green energy sources such as wind, solar, green hydrogen, and green ammonia.
Purpose-driven Technologies. Creative business models that provide broad access to improved precision and efficiency through applications of AI-based tools, Robotics, SaaS, Business Process Automation, 5G WiFi, and Low Earth Orbit (LEO) satellite technologies.
Financial Services. FinTech, Insurtech, Carbon Credit monetization platforms, and blockchain-based services that unlock value through digital products and services that are Smarter, Faster, More Secure, and More Accessible
Healthcare Innovations. Novel therapeutic platforms enabled by AI-enabled synthetic biologic innovation whose clinical evidence shows promising potential for increased safety and improved patient outcomes
Food System Resilience. Agritech, Smart Vertical Greenhouse technologies, and Delivery Solutions that help improve Food Safety, Traceability, Production Efficiencies, and Supply Chain Resilience
We invite you to scroll through case examples below. If you are a Broadline registered investor, please click on the "Investor Login" tab at the top of this website for management reports from current portfolio companies.
ENDOSCOPIC Medical Devices
EndoSphere is a medical technology company that has developed a first-in-class, less-invasive medical device platform to treat metabolic diseases, including some of the world's largest healthcare issues such as Obesity, Type 2 Diabetes, and Fatty Liver Disease. EndoSphere's novel "Endo-Metabolic" device platform represents a completely new category of devices that is the first to uniquely focus on the Duodenum, the upper intestinal organ that is widely recognized as the body's metabolic control center. Endosphere's flagship anti-obesity device is incisionless, reversible and repeatable. In clinical studies, the device enabled Obese patients to achieve significant Excess Weight Loss (EWL) without the need for more invasive alternatives. Unlike restrictive devices and bariatric surgeries, which typically work against nature, EndoSphere's "Endo-Metabolic" devices work with the body by amplifying its physiological responses to food intake in order to help accelerate satiation, recalibrate brain-gut metabolic feedback loops, recalibrate hormones, and rebalance insulin levels. EndoSphere's patent asset portfolio is 100% company-owned and free from any third-party licensing or royalty obligations. EndoSphere has received numerous industry recognitions, including the industry's "Fierce15" award, named by FierceBiotech, which annually recognizes the world's most promising privately-held medical innovations. The original version of its anti-obesity device received CE Mark (regulatory approval in 31 countries), and an enhanced version has entered clinical stages of development. For more information, visit https://www.endo-sphere.com.
Energy Storage Innovations
Carbon-Free Lithium-ion and Solid State BatterY CATHODES
Powermers has created the world's first Carbon-Free Cathodes for lithium-ion and solid state batteries. They did it by replacing "inactive/deadweight" material (carbon, binders and solvents) with proprietary conductive polymers. Powermers' transition-metal polymers demonstrate higher catalytic functionality than pure noble-metal catalysts (including gold, platinum, and palladium). Their differentiated results in Safety and Energy Capacity are documented in industry peer-review publications including American Chemical Society's Applied Materials & Interfaces. 5 measurable advantages have been Independently validated by U.S. Army Corps of Engineers (CERL) and universities around the world including the Center for Automotive Research at The Ohio State University (O.S.U. C.A.R.). For more information, please visit https://www.powermers.com.
- Safer: Our simplified cathode increases Safety and Stability by reducing Thermal Runaway Risk (the prevailing cause of battery combustion).
- Less Toxic: Reduces reliance on Toxic Solvents.
- Higher Energy: Expands the Active Material Limit, increasing Energy without sacrificing Power, Cycle Life, Weight, or Cost per KWH.
- Drop-in Replacement: Enables ease of adoption into established battery manufacturing processes.
- Reduced Cost per KWH: Total Cost per KWH is also enabled by the decreased reliance on costly toxic solvents.
We're extremely excited about the collegial team of professionals at Broadline Capital. Our investment leaders have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in the history of their categories. They understand what it takes to align multiple stakeholders toward a shared vision and develop a successful business, because they've done it. At Broadline, we love going back to our roots by collaborating with management teams that are highly credible, focused, and inspired to achieve a shared vision.
Our investment leaders are past CEOs and entrepreneurs whose prior companies created significant value and achieved quality exits on behalf of themselves and their investors. They've excelled in prior careers at top firms (such as McKinsey, Morgan Stanley, General Electric, Apple, Brunswick, Oppenheimer Capital, Allergan, Pfizer, Roche, and PwC) and completed training at recognized educational institutions (collectively earning 46 degrees, including 21 advanced degrees and 11 doctorates). Our combined experience and relationships enable Broadline to contribute unique value beyond capital for Broadline-supported companies.
"At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are working to transform their ideas into the next big, industry-changing company."
If you share our perspective, we look forward to hearing from you. Please direct inquiries to: email@example.com
Broadline® is a Registered Trademark.
Copyright © Broadline Capital LLC 2005-2023.
All Rights Reserved.